#8400. Thrombo-inflammatory biomarkers to predict sepsis outcome

October 2026publication date
Proposal available till 30-05-2025
4 total number of authors per manuscript4500 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Medicine (all);
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeFreeFree
1350 $1200 $1050 $900 $
Contract №8400.1 Contract №8400.2 Contract №8400.3 Contract №8400.4
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)

Abstract:
Sepsis has been redefined recently as life-threatening organ dysfunction caused by dysregulated host responses to infection and septic shock. Soluble urokinase plasminogen activator receptor (SuPAR) and plasminogen activator inhibitor-1(PAI-1) concentration positively correlate to the activation level of the immune system, and are markers of disease severity and aggressiveness. The study aimed to identify the blood level of plasminogen activator inhibitor-1 (PAI-1) and soluble urokinase plasminogen activator receptor (SuPAR) in sepsis and its association with mortality.
Keywords:
plasminogen activator inhibitor-1; sepsis; soluble urokinase plasminogen activator receptor

Contacts :
0